The results of the association tests between rs1042522/rs2279744 polymorphisms of TP53/MDM2 genes with the occurrence of bladder cancer under different genetic models: allele contrast, recessive, dominant, as well as homozygous and heterozygous models are represented in Table 2. This evidence concerns the gene MDM2 and urinary bladder cancer.